Effect of sex and gestational age on neonatal body composition

Laure Simon1, Paula Borrego, Dominique Darmaun

  • 1Department of Neonatal Medicine, Hôpital Mère-et-Enfant, CHU de Nantes, 44093 Nantes cedex 1, France.

Insights

Preterm infants have higher body fat percentage than full-term newborns due to lower lean body mass accretion. This difference is more pronounced in preterm boys compared to girls.

Area of Science:

  • Neonatalogy
  • Pediatric Body Composition
  • Infant Physiology

Background:

  • Infant body composition is influenced by gestational age and sex.
  • Understanding these factors is crucial for assessing infant health and development.
  • Air displacement plethysmography is a reliable method for measuring body composition.

Purpose of the Study:

  • To investigate the impact of gestational age (term vs. preterm) and sex on infant body composition.
  • To compare fat mass and lean body mass percentages between term and preterm neonates.
  • To identify sex-specific differences in body composition within term and preterm groups.

Main Methods:

  • Air displacement plethysmography was used to assess body composition.
  • The study included 46 full-term neonates and 180 preterm neonates.
  • Measurements were taken at different time points: 3 days of life for term infants and prior to discharge for preterm infants.

Main Results:

  • Preterm infants exhibited a higher percentage of body fat (13.4%) compared to term infants (10.1%).
  • Absolute fat mass did not differ, but lean body mass was significantly lower in preterm infants.
  • In term infants, females had higher fat mass percentage than males; no sex difference was observed in preterm infants.

Conclusions:

  • Preterm infants have a greater body fat percentage upon hospital discharge compared to term infants.
  • This is likely due to reduced lean body mass accretion during early extra-uterine life.
  • The findings suggest potential sex-related differences in lean body mass accretion in preterm infants, particularly affecting boys.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Two-Way ANOVA01:17

Two-Way ANOVA

The two-way ANOVA is an extension of the one-way ANOVA. It is a statistical test performed on three or more samples categorized by two factors - a row factor and a column factor. Ronald Fischer mentioned it in 1925 in his book 'Statistical Methods for Researchers.'
The two-way ANOVA analysis initially begins by stating the null hypothesis that there is an interaction effect between the two factors of a dataset. This effect can be visualized using line segments formed by joining the means for...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...